SciELO - Scientific Electronic Library Online

vol.40 número1Establecimiento de la línea PL104 Modelo de estudio del balance muerte/sobrevida de células tumorales índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados


Acta bioquímica clínica latinoamericana

versión impresa ISSN 0325-2957versión On-line ISSN 1851-6114


AMBROSIO, Ana María; SAAVEDRA, María del Carmen; RIERA, Laura Marisa  y  FASSIO, Rubén Miguel. Argentine production of live attenuated vaccine candid #1 to prevent argentine hemorrhagic fever. Acta bioquím. clín. latinoam. [online]. 2006, vol.40, n.1, pp.5-17. ISSN 0325-2957.

The emergence of Argentine hemorrhagic fever (AHF) at the beginning of the ´50s represented an exceptional challenge to Argentine scientists: a new human pathology with a high lethality rate was affecting a conspicuous region -of high economical importance- of the Argentine territory. Facing this challenge with dedication and, undoubtedly, more intellectual than financial resources, made it possible that three years after the clinical description of the disease, Junin virus was shown to be its etiological agent, being this the second arenavirus reported, following the prototype of the arenavirus group Lymphocytic Choriomeningitis virus, isolated in 1933. During the ´60s and ´70s fundamental progress was made with the demonstration of Junin virus natural reservoir and many findings on the physiopathology and epidemiology of AHF, being already envisioned that this was a controllable but not an eradicable disease. During this same period the therapeutical use of convalescent´s plasma (neutralizing antibodies transference) was shown to dramatically decrease the mortality rate of the disease, and several important research projects were started to develop an efficacious vaccine to control AHF. This paper is a non exhaustive chronicle of events that led to the manufacture of a vaccine (Candid #1) against AHF in Argentina, and was written to honor Dr. Ricardo Margni, a great immunologist. It is also intented to show one of the many ways in which immunology principles, diffused by Dr. Margni along his rich research and teaching background, can improve society’s life quality.

Palabras clave : Argentine hemorrhagic fever; Arenaviridae; Candid #1 vaccine; Argentine manufacture of viral vaccines.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons